Use of tuberculin skin test, IFN-γ release assays and IFN-γ-induced protein-10 to identify children with TB infection

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 644-648

  Yassin, Mohammed A ^a,b   Petrucci, Roberta ^c   Garie, Kefyalew T ^d   Harper, Greg ^a   Teshome, Aklilo ^e   Arbide, Isabel ^e   Asnake, Girum ^f   Ahmed, Habiba J ^e   Mammoe, Tadesse ^f   Yesuf, Kedir ^g   Cuevas, Luis E ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b TUBERCULOSIS AND MALARIA   (Switzerland)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Faculty of Medicine   (Hungary)

^e Bushullo Major Health Centre   (Hungary)

^f Hawassa Health Centre   (Hungary)

^g Southern Region Health Bureau   (Ethiopia)

Author keywords

Children; Diagnosis; Interferon c; Interferon c induced protein 10; Latent tuberculosis; Tuberculin skin test

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; TUBERCULIN;

ADOLESCENT; ARTICLE; BACTERIAL LOAD; CHILD; CONTACT EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELISA KIT; FEMALE; HIGH RISK POPULATION; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPUTUM SMEAR; STANDARD; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ETHIOPIA; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA RELEASE TESTS; MALE; MASS SCREENING; SKIN TESTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84875237097     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00012212     Document Type: Article

References (18)

1. Almeida LM, Barbieri MA, Da Paixao AC, et al. Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J 2001; 20: 1061-1065.
2. Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-c release assays and childhood tuberculosis: Systematic review and meta-analysis. Int J Tuberc Lung Dis 2011; 15: 1018-1032.
3. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNc? PLoS One 2008; 3: E3901.
4. Goletti D, Raja A, Syed Ahamed Kabeer B, et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 2010; 5: E12577.
5. Yassin MA, Petrucci R, Garie KT, et al. Can interferon-c or interferon-c-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas? PLoS One 2011; 6: E23733.
6. Marais BJ, van Zyl S, Schaaf HS, et al. Adherence to isoniazid preventive chemotherapy: A prospective community based study. Arch Dis Child 2006; 91: 762-765.
7. van Wyk SS, Reid AJ, Mandalakas AM, et al. Operational challenges in managing isoniazid preventive therapy in child contacts: A high-burden setting perspective. BMC Public Health 2011; 11: 544.
8. van Zyl S, Marais BJ, Hesseling AC, et al. Adherence to antituberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis 2006; 10: 13-18.
9. Garie KT, Yassin MA, Cuevas LE. Lack of adherence to isoniazid chemoprophylaxis in children in contact with adults with tuberculosis in southern Ethiopia. PLoS One 2011; 6: E26452.
10. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
11. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-crelease assays for tuberculosis infection: Concordance, discordance or confusion? Clin Microbiol Infect 2011; 17: 806-814.
12. Mandalakas AM, Detjen AK, Hesseling AC. Can we accurately diagnose tuberculosis infection in children? Pediatr Infect Dis J 2011; 30: 817-818.
13. World Health Organization. Use of tuberculosis interferon-gamma release assays in low-and middle-income countries. www.who. int/tb/features-archive/ policy-statement-igra-oct2011.pdf Date last accessed: June 2012. Date last updated: 2011.
14. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-c release assays for incident active tuberculosis: A systematic review andmeta-analysis. Lancet Infect Dis 2012; 12: 45-55.
15. Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: A cost effectiveness analysis. BMC Pulm Med 2010; 10: 7.
16. Ruhwald M, Bodmer T, Maier C, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008; 32: 1607-1615.
17. Ruhwald M, Dominguez J, Latorre I, et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis 2011; 91: 260-267.
18. Kampmann B, Whittaker E, Williams A, et al. Interferon-c release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009; 33: 1374-1382.